214 related articles for article (PubMed ID: 11841367)
1. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes.
Bladon J; Taylor PC
Br J Dermatol; 2002 Jan; 146(1):59-68. PubMed ID: 11841367
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients.
Bladon J; Taylor PC
Br J Haematol; 1999 Dec; 107(4):707-11. PubMed ID: 10606873
[TBL] [Abstract][Full Text] [Related]
3. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
Holien T; Gederaas OA; Darvekar SR; Christensen E; Peng Q
Lasers Surg Med; 2018 Jul; 50(5):469-475. PubMed ID: 29460964
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis: a focus on apoptosis and cytokines.
Bladon J; Taylor PC
J Dermatol Sci; 2006 Aug; 43(2):85-94. PubMed ID: 16797926
[TBL] [Abstract][Full Text] [Related]
5. The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization.
Bladon J; Taylor PC
Transpl Int; 2006 Apr; 19(4):319-24. PubMed ID: 16573548
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cutaneous T cell lymphoma with extracorporeal photopheresis induces Fas-ligand expression on treated T cells, but does not suppress the expression of co-stimulatory molecules on monocytes.
Bladon J; Taylor PC
J Photochem Photobiol B; 2003 Feb; 69(2):129-38. PubMed ID: 12633985
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
8. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction.
Bladon J; Taylor PC
Transplant Proc; 2003 Jun; 35(4):1328-32. PubMed ID: 12826151
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
Bladon J; Taylor P
J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease.
Di Renzo M; Rubegni P; Pasqui AL; Pompella G; De Aloe G; Sbano P; Cuccia A; Castagnini C; Auteri A; Laghi Pasini F; Fimiani M
Br J Dermatol; 2005 Jul; 153(1):59-65. PubMed ID: 16029327
[TBL] [Abstract][Full Text] [Related]
11. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
[TBL] [Abstract][Full Text] [Related]
12. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
Spisek R; Gasova Z; Bartunkova J
Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
14. Updating ECP action mechanisms.
Heshmati F
Transfus Apher Sci; 2014 Jun; 50(3):330-9. PubMed ID: 24837416
[TBL] [Abstract][Full Text] [Related]
15. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
Atta M; Papanicolaou N; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
[TBL] [Abstract][Full Text] [Related]
16. Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease.
Craciun LI; Stordeur P; Schandené L; Duvillier H; Bron D; Lambermont M; Goldman M; Dupont E
Transplantation; 2002 Oct; 74(7):995-1000. PubMed ID: 12394844
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay.
Chieregato K; Alghisi A; Borghero C; Elice F; Raimondi R; Zanetti E; Rodeghiero F; Astori G
Transfus Apher Sci; 2015 Oct; 53(2):242-5. PubMed ID: 26051797
[TBL] [Abstract][Full Text] [Related]
18. T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy.
Schmid D; Grabmer C; Streif D; Lener T; Schallmoser K; Rohde E
Vox Sang; 2015 Jan; 108(1):82-8. PubMed ID: 25333914
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photoimmunotherapy-photopheresis.
Dani T; Knobler R
Front Biosci (Landmark Ed); 2009 Jan; 14(12):4769-77. PubMed ID: 19273388
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
Owsianowski M; Garbe C; Ramaker J; Orfanos CE; Gollnick H
Hautarzt; 1996 Feb; 47(2):114-23. PubMed ID: 8868455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
